DP
Devon Park BioVentures
Venture CapitalActiveDevon Park Bioventures, located in the Philadelphia metropolitan area, is within driving distance of the headquarters of many of the worlds
Wayne, United StatesFounded 2014
15
Investments
4
Exits
$250M
AUM
26.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Devon Park BioVentures.
Investment Thesis & Strategy
Devon Park BioVentures invests in various stages of companies within the biotechnology and life sciences industries, specifically targeting those located in the Philadelphia metropolitan area. They seek companies with strong potential for growth and innovation.
Investment Activity
Deals per year over the last 21 years
1
20020
20030
20040
20050
20060
20070
20080
20090
20100
20110
20120
20130
20140
20150
20160
20173
20180
20192
20203
20212
2022Portfolio Companies
Selected investments from their portfolio of 15 companies
V
Vinta Bio
Biotech · Series A, 2022
I
Immutherapeutics
Biotech · Series A, 2022
V
Vivaris
Biotech · Series A, 2021
E
Exuma Biotech
Biotech · Series A, 2021
A
Aegle Therapeutics
Biotech · Series A, 2021
C
Chimeron Bio
Biotech · Seed, 2020
I
Imvax
Biotech · Series B, 2020
V
Vaxcyte
Biotech · Series B, 2018
C
Cabaletta Bio
Biotech · Series B, 2018
T
Taris Biomedical
Biotech · Series B, 2018
I
Incyte
Biotech · Growth, 2002
Notable Exits
CompanyTypeYearValue / Acquirer
ObsidioAcquisition2024—
InCarda TherapeuticsAcquisition2023—
VaxcyteIPO2020—
Avenue TherapeuticsIPO2017—
Frequently Asked Questions
Devon Park BioVentures focuses on Series A, Series B, Series C+ stage investments.